<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"
        xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
        xmlns:image="http://www.google.com/schemas/sitemap-image/1.1"
        xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd http://www.google.com/schemas/sitemap-news/0.9 http://www.google.com/schemas/sitemap-news/0.9/sitemap-news.xsd http://www.google.com/schemas/sitemap-image/1.1 https://www.google.com/schemas/sitemap-image/1.1/sitemap-image.xsd">
    <url>
      <loc>https://www.israeldailyvoice.com/article/906375683-arbe-announces-receipt-of-nasdaq-notification-regarding-minimum-bid-price-deficiency</loc>
      <news:news>
        <news:publication>
          <news:name>Israel Daily Voice</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-17T21:20:00+00:00</news:publication_date>
        <news:title>Arbe Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/NmE0ZTA1OTgtNWRjMi00MTExLThhZDQtYjdkNTUzMmM4OWQ4LTUwMDEyOTY2Ny0yMDI2LTA0LTE3LWVu/tiny/Arbe-Robotics-Ltd-.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.israeldailyvoice.com/article/906350191-biolojic-design-presents-new-preclinical-data-for-bd200-a-first-in-class-multibody-drug-conjugate-targeting-trop-2-and-nectin-4-at-the-american</loc>
      <news:news>
        <news:publication>
          <news:name>Israel Daily Voice</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-17T19:00:00+00:00</news:publication_date>
        <news:title>Biolojic Design Presents New Preclinical Data for BD200, a First-in-Class Multibody-Drug Conjugate Targeting Trop-2 and Nectin-4 at the American Association of Cancer Research Annual Meeting</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/5e7e1405-b691-484b-818b-1cb571d71d5c/small/biolojic-design-logo-vertical-color-resized-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.israeldailyvoice.com/article/906310715-odysight-ai-signs-commercial-collaboration-agreement-with-gaci-technologies-to-expand-ai-powered-predictive-maintenance-into-the-french-aerospace-and</loc>
      <news:news>
        <news:publication>
          <news:name>Israel Daily Voice</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-17T12:30:00+00:00</news:publication_date>
        <news:title>Odysight.ai Signs Commercial Collaboration Agreement with GACI Technologies to Expand AI-Powered Predictive Maintenance into the French Aerospace and Defense Market</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/fe840a3d-d94f-4b27-ba22-45a8615ddcfb/small/screenshot-2-jpg.jpg</image:loc>
        </image:image>
    </url>
</urlset>
